drugset / Trial / NCT00006225
Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer
RandomizedTreatment
Summary
RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy or radiation therapy. PURPOSE: Randomized phase I/II trial to study the effectiveness of peripheral stem cell transplantation in treating patients who have breast cancer or hematologic cancer.
Timeline
- Start
- 1999-11
- Primary completion
- 2004-01
- Completion
- 2004-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | filgrastim | Protein / enzyme biologic | — | — |
| Background | flt3 ligand | Protein / enzyme biologic | — | — |
| Background | interleukin-3 | Protein / enzyme biologic | — | — |
| Background | recombinant human thrombopoietin | Protein / enzyme biologic | — | — |